Please provide your email address to receive an email when new articles are posted on . Later idiopathic intracranial hypertension diagnoses occurred less often in women with slightly lower ...

A new study has revealed important clues about how vision damage develops in people with a serious condition called idiopathic intracranial hypertension, also known as IIH. The research may also help ...

Int Ophthalmol Clin. 2014;54(1):27-41. Much of the data supporting weight loss as treatment for IIH comes from retrospective studies or class III evidence. There has been a long-standing need for ...

Patients with ‘blinding’ headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The study, published ...

Int Ophthalmol Clin. 2014;54(1):103-114. Topiramate is typically started at 25 mg daily and can be titrated up to 100 mg twice daily. It is frequently given in addition to acetazolamide in the ...

USA: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may offer a more effective therapeutic option than conventional ...

Patients with 'blinding' headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The study, published ...

Patients with idiopathic intracranial hypertension lost weight and had fewer headaches with GLP-1 receptor agonists, ...

Intracranial hypertension (IH), a clinical condition typically seen in the intensive care unit, is caused by increased pressure surrounding the brain. In many situations, the cause of chronic IH is ...

A new study led by investigators from Mass General Brigham shows that a brain waste- “clean-up” system is influenced by intracranial pressure. The system, called the glymphatic system, was ...